Incannex Healthcare (IXHL) Total Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Total Liabilities of $5.0 million for Q1 2026, down 42.59% year-on-year from $8.8 million in Q1 2025, and up 215.56% on a QoQ basis from $1.6 million in Q4 2025.
Incannex Healthcare (IXHL) Total Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Total Liabilities for 7 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- Quarterly Total Liabilities fell 42.59% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (down 42.59% YoY) and the FY2025 annual result came in at $7.1 million, up 21.06% from the prior year.
- Total Liabilities rose to $5.0 million in Q1 2026 per IXHL's latest filing, from $1.6 million in the prior quarter.
- Over the last five years, Total Liabilities for IXHL reached as high as $10.1 million in Q4 2024 and fell as low as $1.3 million in Q4 2022.
- A 5-year average of $4.8 million and a median of $3.5 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 190.82% — and 2025, when it plunged 84.22%.
- Year by year, Total Liabilities stood at $1.3 million in 2022, then soared by 168.0% to $3.5 million in 2023, then surged by 190.82% to $10.1 million in 2024, then tumbled by 84.22% to $1.6 million in 2025, then soared by 215.56% to $5.0 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $5.0 million, $1.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 5.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.05 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 8.79 Mn |
| Dec 31, 2024 | 10.14 Mn |
| Sep 30, 2024 | 9.45 Mn |
| Jun 30, 2024 | 5.83 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Jun 30, 2023 | 2.96 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 1.07 Mn |